Figure 2From: Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIBThe association of overall survival with the percentage of CD133+ cells in colon carcinoma patients with Stage IIIB. The patients with a lower percentage of CD133+ cells (<5%) in the cancer nests were strongly associated with longer 5-year survival than those with a higher percentage of CD133+ cells (≥5%).Back to article page